source
- John Powers III named permanent director of NIAID after year-long vacancyThe National Institute of Allergy and Infectious Diseases announced that its acting head, John Powers III, will become the institute’s permanent director. Powers, a physician‑scientist, has been w…
- CDC finds 10% of U.S. adults used GLP-1 drugs in 2025, 20% of them took compounded versions; Russia may seize foreign drug IPThe Centers for Disease Control and Prevention reported that during July and August 2025 roughly one in ten U.S. adults said they had taken a GLP-1 medication at some point in the prior year. Amon…